Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  mivobulin isethionate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-14 of 14 for your search:
Start Over
Phase I/II Study of CI-980 for Recurrent or Progressive Malignant Glioma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-NCNSC-95003, NCI-T95-0101O, T95-0101
Phase I/II Study of CI-980 for Newly Diagnosed Malignant Glioma (Summary Last Modified 09/2000)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NABTT-9602, JHOC-NABTT-9602, NCI-T96-0027H
Phase II Study of CI-980 for Advanced Soft Tissue Sarcomas (Summary Last Modified 07/98)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-95217, NCI-T95-0102H, T95-0102
Phase II Study of CI-980 in Metastatic Malignant Melanoma (Summary Last Modified 06/1999)
Phase: Phase II
Type: Treatment
Status: Completed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-S9622, SWOG-9622, S9622
Phase II Study of CI-980 for Advanced non-Small Cell Lung Cancer (Summary Last Modified 01/98)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-8182, NCI-T96-0008H, T96-0008
Phase II Study of CI-980 for Advanced Melanoma (Summary Last Modified 08/1999)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-8183, NCI-T96-0007H, T96-0007
Phase II Study of CI-980 for Hormone-Refractory Stage D2 Prostate Cancer (Summary Last Modified 08/1999)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-8254, NCI-T96-0048H, T96-0048
Phase II Study of CI-980 in Untreated Extensive Stage Small Cell Lung Cancer (Summary Last Modified 09/1999)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-9614, OSU-T96-9614, NCI-T96-0020H, T96-0020
Phase II Trial of CI-980 in Advanced Renal Cell Carcinoma (Summary Last Modified 04/98)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-8184, NCI-T96-0006H, T96-0006
Phase I Study of CI-980 as a 72-Hour Infusion with and without G-CSF for Advanced Solid Tumors (Summary Last Modified 02/95)
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: JHOC-T93-0186, NCI-T93-0186D, T93-0186
Phase I Study of CI-980 for Primary Adult Brain Tumors (Summary Last Modified 06/97)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMCC-9316, NCI-T93-0194O, T93-0194
Phase I Study of CI-980 by Continuous Infusion Over 72 Hours in Refractory Pediatric Solid Tumors (Summary Last Modified 06/97)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-9470
Phase I Study of CI-980 with and without G-CSF in Children with Relapsed Acute Leukemia (Summary Last Modified 01/99)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-9472
Phase I Study of CI-980 in Patients with Advanced Solid Tumors
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor:
Protocol IDs: AECM-9008246, NCI-V92-0009
Start Over